Superficial, Palpable, Unresectable/Metastatic Solid Tumour
1 clinical trials · Condition
◉ Watch Superficial, Palpable, Unresectable/Metastatic Solid Tumour
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate Safety & Tolerability of AGI-134 in Solid Tumour (NCT03593226) | Agalimmune Ltd. | 2018-11-30 |
Track Superficial, Palpable, Unresectable/Metastatic Solid Tumour automatically
Every clearance here is in the API, with alerts when new ones post.